According to a latest research report by RNCOS, communicable diseases have been replaced by a number of chronic diseases in the E7 countries over the past few years. On the back of improving healthcare infrastructure, increasing life expectancy, and aging population, it is expected that this pattern will acquire much stronger growth with the aging population in the developing countries. Taking India as an example setter, the prevalence of chronic and lifestyle-related diseases is projected to grow at a rapid rate in future, creating a strong demand for drugs against these indications.
A strong growth has been witnessed over the last few years in the pharmaceutical markets of the E7 countries, owing to increasing healthcare spending, disease profile, and government support. According to the latest report by RNCOS, “Emerging Pharmaceutical Markets Globally”, fast growth in population and increasing income levels will still be the prevailing factors for the high growth in the coming years. Also, increasing penetration of health insurance has constructed a solid platform for stronger pharmaceutical market growth.
The report, “Emerging Pharmaceutical Markets Globally” provides an in-depth research and rational analysis of the current status and future scenario of the pharmaceutical market in E7 countries. It facilitates the future forecasts for the each country’s pharmaceutical market during 2011-2014. The report also provides the current data on the branded and generic drugs, imports and exports, key players and disease profile of each country. Additionally, analysis of the healthcare spending has been included in the report to provide a balanced outlook on the potentials of the E7 pharmaceutical industry.
Some of our Related Reports are:
- Booming Clinical Trials Market in India
- Global Obesity Drug Market Analysis
- Global Telemedicine Market Analysis
- Clinical Trials Market in Russia
- Indian Pharma Sector Forecast 2014
|
